U.S. Aerospace & Defense Stock News

Fluence Energy (FLNC) drew investor attention after UBS upgraded the stock from Sell to Neutral, citing expectations for stronger five-year revenue trends and rising demand for battery storage in solar-plus-storage projects. See our latest analysis for Fluence Energy. At a share price of US$11.24, Fluence Energy has seen its 1-day share price return rise 3.5% after the UBS upgrade, although the 90-day share price return is down 47.03% while the 1-year total shareholder return is 48.28%. This...

Autodesk (ADSK) heads into its upcoming earnings report with analysts expecting year over year growth in both earnings and revenue, and investors watching how the subscription model is shaping performance across its main product lines. See our latest analysis for Autodesk. Autodesk's recent 30 day share price return of 19.77% contrasts with a year to date share price decline of 12.39%. The 3 year total shareholder return of 14.50% points to slower longer term momentum despite the latest...

Robotaxis moving into Munich and trials in Tokyo and London signal that autonomous driving is shifting from pilot projects to real city streets. That matters for investors because when regulation, infrastructure and competition start to line up, expectations can reset quickly and fear of missing early movers grows. This article unpacks three stocks exposed to this robotaxi news and explains how each could benefit if the trend builds from here. The stocks below are just a starting sample, and...

FedEx stock has surged over the past year, yet valuation checks suggest the shares may still trade below an estimate of intrinsic value based on a Discounted Cash Flow (DCF) approach and earnings multiples that both screen as undervalued. FedEx has delivered a 82.8% return over the past year, which puts fresh focus on whether that move has already priced in the company’s improvement plans or still leaves room relative to fundamentals. The ongoing Network 2.0 consolidation, including facility...

Abercrombie & Fitch (NYSE: ANF) appointed Mary Fox, President of Lovesac, to its Board of Directors. Fox brings leadership experience in omnichannel retailing, marketing, and business transformation from roles at Lovesac, BIC, L'Oréal, and Walmart. The board appointment highlights a focus on retail operations and brand positioning that could influence Abercrombie & Fitch's future direction. For investors looking beyond Abercrombie & Fitch to other companies tied to changing retail and...

L3Harris Technologies (NYSE:LHX) appointed Sam Mehta as CEO and President, alongside extensive leadership and board changes. The company reshuffled its board leadership and introduced new executive roles, indicating a refreshed governance structure. L3Harris highlighted advanced multi domain defense and interoperable communications capabilities at recent key U.S. Army events. The leadership moves and technology showcases reflect a meaningful shift in how L3Harris positions itself within the...

United Community Banks (UCB) recently drew investor attention after its board approved a 4% rise in the quarterly cash dividend to $0.26 per share, along with several senior leadership changes across finance and commercial banking. See our latest analysis for United Community Banks. At a share price of $35.11, United Community Banks has given investors an 11.64% year to date share price return. The 1 year total shareholder return of 9.35% and 3 year total shareholder return of 42.01% point to...

Atlanticus Holdings (ATLC) recently announced a quarterly cash dividend of $0.476563 per share on its Series B Cumulative Perpetual Preferred Stock, a move that draws attention to the capital structure behind the common stock. See our latest analysis for Atlanticus Holdings. At a share price of $93.95, Atlanticus Holdings has given investors a year to date share price return of 41.60%, while the 1 year total shareholder return of 41.19% and 3 year total shareholder return of 166.15% point to...

United States Antimony has delivered an extremely strong 3 year share price return, yet its current valuation signals are pulling in different directions, with a Discounted Cash Flow (DCF) estimate pointing to a large gap to intrinsic value while market multiples suggest the stock screens as expensive. Over the past 3 years, United States Antimony has returned very large multiples for shareholders, which puts extra focus on whether the current price can be justified by future cash flows. The...

Campbell's stock has had a difficult run over the past few years, yet the current checks on its valuation still lean toward the shares looking cheap rather than expensive. Campbell's shareholders have seen the stock decline 36.5% over the past 3 years, which raises the question of whether sentiment has swung too far compared with the underlying business. Future valuation can be influenced by how consistently Campbell's converts revenue into cash flow. Any sustained pressure on margins would...

Novo Nordisk stock combines a weak three year share price record with valuation checks that still lean supportive, which raises questions about how much pessimism is already reflected in today’s price. Over the past three years the share price has declined 45.7%, which suggests investors have meaningfully reset their expectations for the business. Expectations around Novo Nordisk’s ability to grow and defend its position in the obesity treatment market can support the investment case. At the...

PepsiCo recently appointed Nidhima M., a veteran HR leader with nearly 19 years of global experience, as Senior Director of HR for India, Bangladesh and Nepal, while also preparing to release its third-quarter 2026 results and deepening its commercial partnership with autonomous trucking firm Gatik. These developments highlight PepsiCo’s growing emphasis on international leadership, technology-enabled logistics, and overseas operations as central pillars of its longer-term diversification...

Septerna, Inc. recently appointed Rajiv Patni, M.D., as Chief Medical Officer, adding a physician-scientist with more than 25 years of global biopharmaceutical leadership experience across research, development, regulatory, and medical affairs roles. His track record contributing to 10 regulatory approvals or label expansions and leadership roles at companies that were later acquired may influence how investors view Septerna’s ability to advance its pipeline and execute on clinical...

Talks over new shipping routes and mine clearance in the Strait of Hormuz are reshaping how investors think about oil flows and risk. When a chokepoint for global crude looks a little less fragile yet still uncertain, pricing, margins and capital plans for integrated energy giants can all come under review. This article walks through three large oil and gas stocks exposed to this news and how the shifting risk picture could matter for your portfolio. The three integrated giants covered below...

In August 2026, Merck & Co. and Moderna reported positive Phase 3 results from the INTerpath-001 trial, showing that individualized mRNA neoantigen therapy intismeran (V940/mRNA-4157) plus KEYTRUDA improved recurrence-free and distant metastasis-free survival versus KEYTRUDA alone in resected stage IIB–IV melanoma, with no new safety signals. This is the first positive Phase 3 outcome for both an individualized neoantigen therapy and an mRNA-based cancer therapy, highlighting a potential...

Waste Connections stock has delivered a 33.4% total return over the last five years, yet the current valuation signals are split. The intrinsic value estimate from a Discounted Cash Flow (DCF) model points to upside relative to the market price, while earnings based multiples suggest the shares trade at a premium. The 33.4% five year return suggests Waste Connections has already created solid value for long term shareholders, so fresh buyers now need to think carefully about what is priced...

Argan stock has delivered an exceptionally strong move over the past three years, yet on the current checks it screens as expensive rather than a clear bargain. After that run, investors are now facing a share price that has pulled back recently but still carries a low overall value score and an overvalued read on market multiples. Argan has returned very roughly 10x over the past three years, which means even small changes in expectations can have a meaningful impact on what feels like a...

JD.com (NasdaqGS:JD) has drawn fresh investor attention after committing RMB 10 billion to a global robotics push by 2028, targeting homes, businesses, and public services with extensive after-sales networks and new engineering jobs. See our latest analysis for JD.com. Investors have reacted only modestly so far, with JD.com’s 7 day share price return of 1.87% and year to date share price return roughly flat. The 1 year total shareholder return is down 4.48%, suggesting momentum is still...

Tompkins Financial recently announced a quarterly dividend of US$0.70 per share, lifting its annualized payout to US$2.80, an increase of 11.6% from the prior year and ahead of the Banks – Northeast industry yield, alongside expectations for higher earnings in its current fiscal year. This combination of sustained dividend growth and an anticipated improvement in earnings has reinforced Tompkins Financial’s income and quality-focused appeal for investors. We’ll now examine how Tompkins...

Axos Financial (AX) has drawn fresh attention after recent trading data showed the stock at $98.82 as of 25 August 2026, with performance figures available for the past week, month and past 3 months. See our latest analysis for Axos Financial. Over the past year Axos Financial has paired a strong 13.46% 90 day share price return with a 131.16% three year total shareholder return. This suggests recent momentum has added to an already sizeable long term payoff for investors tracking both price...

Monolithic Power Systems (MPWR) is back in focus after reporting strong growth in its Enterprise Data segment, which highlights rising demand for its power management solutions across data centers, AI workloads, and server infrastructure. See our latest analysis for Monolithic Power Systems. At a share price of $1,304.15, Monolithic Power Systems has seen its short term share price return weaken, with the 90 day share price return down 19.51%, even though the year to date share price return...

Kennametal (KMT) has added Dawne S. Hickton and Richard J. Harshman to its Board of Directors, a governance event that gives investors fresh context for assessing the stock after recent share price moves. See our latest analysis for Kennametal. The new board appointments arrive after a mixed stretch for Kennametal, with the share price falling 16.9% over the past month and 15.8% over the past quarter, even as the 1 year total shareholder return is 39.9%, which suggests longer term momentum...

Monte Rosa Therapeutics (GLUE) dosed the first patient in its MODeFIRe-1 Phase 2 trial of MRT-2359 with apalutamide for AR mutation-positive metastatic castration-resistant prostate cancer, building on earlier combination data with enzalutamide. See our latest analysis for Monte Rosa Therapeutics. The MRT-2359 update comes after a sharp 36.08% decline in the 30-day share price return and a 24.05% decline over 90 days, even as the 1-year total shareholder return of 211.78% and 3-year total...

JPMorgan Chase (NYSE:JPM) and several large US banks have committed billions of dollars to new affordable housing efforts through JPMorgan’s American Dream Initiative. The housing push targets the ongoing national shortage of affordable homes and responds to changing conditions in the US mortgage market. JPMorgan and Morgan Stanley are also facing fresh shareholder lawsuits that question their advisory roles in certain private equity buyouts. The new commitments and legal actions raise fresh...